Is there a drug for every disease?

Pharmaceutical firms in Europe have an awkward relation with their customers. The truth is that their selling prices and product licencing are directly or indirectly controlled by the buyers, that is governments, or government control health insurance schemes, offering almost free health services to citizens. As everybody knows governments are not only able to influence […]

Why banks escape from competition rules but not pharmaceutical firms

Antitrust EU Commission services have an excellent record in identifying, monitoring, substantiating with facts and finally punishing cartels and dominant position abuses. This last week two concrete cases stand witnesses to that.Protecting consumers In the first case the European Court of Justice rejected an appeal against a General Court’s decision, which had upheld almost completely […]